Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Lassmann

Showing results (141-150 of 164) with videos related to

Pageof 17
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|July 25, 2015
EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanomaChristina Bluemel, Ken Herrmann, Francesco Giammarile, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2015
Biodistribution and radiation dosimetry for a probe targeting prostate-specific membrane antigen for imaging and therapyKen Herrmann, Christina Bluemel, Martina Weineisen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 18, 2023
A phase I/II study of the safety and efficacy of [<sup>177</sup>Lu]Lu-satoreotide tetraxetan in advanced somatostatin receptor-positive neuroendocrine tumoursDamian Wild, Henning Grønbæk, Shaunak Navalkissoor, et al.
Clinical Nuclear Medicine|March 15, 2016
68Ga-PSMA-PET/CT in Patients With Biochemical Prostate Cancer Recurrence and Negative 18F-Choline-PET/CTChristina Bluemel, Markus Krebs, Bülent Polat, et al.
Theranostics|May 23, 2017
Imaging of Chemokine Receptor 4 Expression in Neuroendocrine Tumors - a Triple Tracer Comparative ApproachRudolf A Werner, Alexander Weich, Takahiro Higuchi, et al.
Zeitschrift Fur Medizinische Physik|April 24, 2016
Multi-centre evaluation of accuracy and reproducibility of planar and SPECT image quantification: An IAEA phantom studyBrian E Zimmerman, Darko Grošev, Irène Buvat, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 14, 2015
Standardization of administered activities in pediatric nuclear medicine: a report of the first nuclear medicine global initiative project, part 1-statement of the issue and a review of available resourcesFrederic H Fahey, Henry Hee-Seong Bom, Arturo Chiti, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 2, 2016
Standardization of Administered Activities in Pediatric Nuclear Medicine: A Report of the First Nuclear Medicine Global Initiative Project, Part 2-Current Standards and the Path Toward Global StandardizationFrederic H Fahey, Henry Hee-Seung Bom, Arturo Chiti, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 26, 2024
Dosimetry and pharmacokinetics of [<sup>177</sup>Lu]Lu-satoreotide tetraxetan in patients with progressive neuroendocrine tumoursSeval Beykan Schürrle, Uta Eberlein, Catherine Ansquer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 10, 2023
Normal organ dosimetry for thyroid cancer patients treated with radioiodine as part of the multi-centre multi-national Horizon 2020 MEDIRAD projectJan Taprogge, Alex Vergara-Gil, Francesca Leek, et al.
Pageof 17

Showing results (141-150 of 164) with videos related to

Sort By:
Pageof 17
European Journal of Nuclear Medicine and Molecular Imaging|July 25, 2015
EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanomaChristina Bluemel, Ken Herrmann, Francesco Giammarile, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2015
Biodistribution and radiation dosimetry for a probe targeting prostate-specific membrane antigen for imaging and therapyKen Herrmann, Christina Bluemel, Martina Weineisen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 18, 2023
A phase I/II study of the safety and efficacy of [<sup>177</sup>Lu]Lu-satoreotide tetraxetan in advanced somatostatin receptor-positive neuroendocrine tumoursDamian Wild, Henning Grønbæk, Shaunak Navalkissoor, et al.
Clinical Nuclear Medicine|March 15, 2016
68Ga-PSMA-PET/CT in Patients With Biochemical Prostate Cancer Recurrence and Negative 18F-Choline-PET/CTChristina Bluemel, Markus Krebs, Bülent Polat, et al.
Theranostics|May 23, 2017
Imaging of Chemokine Receptor 4 Expression in Neuroendocrine Tumors - a Triple Tracer Comparative ApproachRudolf A Werner, Alexander Weich, Takahiro Higuchi, et al.
Zeitschrift Fur Medizinische Physik|April 24, 2016
Multi-centre evaluation of accuracy and reproducibility of planar and SPECT image quantification: An IAEA phantom studyBrian E Zimmerman, Darko Grošev, Irène Buvat, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 14, 2015
Standardization of administered activities in pediatric nuclear medicine: a report of the first nuclear medicine global initiative project, part 1-statement of the issue and a review of available resourcesFrederic H Fahey, Henry Hee-Seong Bom, Arturo Chiti, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 2, 2016
Standardization of Administered Activities in Pediatric Nuclear Medicine: A Report of the First Nuclear Medicine Global Initiative Project, Part 2-Current Standards and the Path Toward Global StandardizationFrederic H Fahey, Henry Hee-Seung Bom, Arturo Chiti, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 26, 2024
Dosimetry and pharmacokinetics of [<sup>177</sup>Lu]Lu-satoreotide tetraxetan in patients with progressive neuroendocrine tumoursSeval Beykan Schürrle, Uta Eberlein, Catherine Ansquer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 10, 2023
Normal organ dosimetry for thyroid cancer patients treated with radioiodine as part of the multi-centre multi-national Horizon 2020 MEDIRAD projectJan Taprogge, Alex Vergara-Gil, Francesca Leek, et al.
Pageof 17